Organon OGN
NYSE OGN
$13.64 -0.03 (-0.26%)
As of: Sep 10, 2026 · 3:59 PM EDT

Organon (OGN) Total Liabilities (2020 - 2026)

Organon (OGN) posted Total Liabilities of $12.2 billion for Q2 2026, up 0.65% on a QoQ basis from $12.1 billion in Q1 2026, and down 4.66% year-over-year from $12.8 billion in Q2 2025.

Analysis

Organon (OGN) Total Liabilities (2020 - 2026) Analysis & Trends

Organon has reported Total Liabilities for 7 years, with the latest figure at $12.2 billion in Q2 2026.

  • On a quarterly basis, Total Liabilities fell 4.66% year-over-year to $12.2 billion in Q2 2026; TTM through Jun 2026 was $12.2 billion, a 4.66% decrease from a year earlier, with the FY2025 full-year figure at $12.1 billion, down 4.07% from the prior year.
  • Total Liabilities was $12.2 billion for Q2 2026 at Organon, up from $12.1 billion in the prior quarter.
  • The five-year high for Total Liabilities was $12.8 billion in Q2 2025, with the low at $11.5 billion in Q1 2023.
  • Average Total Liabilities over 5 years is $12.0 billion, with a median of $12.1 billion recorded in 2024.
  • The largest YoY upside for Total Liabilities was 140.79% in 2022 against a maximum downside of 11.19% in 2022.
  • Over 5 years, Total Liabilities stood at $11.8 billion in 2022, then increased by 2.37% to $12.1 billion in 2023, then climbed by 4.13% to $12.6 billion in 2024, then slipped by 4.07% to $12.1 billion in 2025, then gained by 0.47% to $12.2 billion in 2026.
  • The last three Total Liabilities figures came in at $12.2 billion (Q2 2026), $12.1 billion (Q1 2026), and $12.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 116.09 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 141.05 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 23.74 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 80.09 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 115.64 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 69.15 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 1.72 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1.53 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 819.80 Mn
10 Organon 3.58 Bn 2.45 Bn 847.00 Mn 12.17 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.17 Bn
Mar 31, 2026 12.09 Bn
Dec 31, 2025 12.12 Bn
Sep 30, 2025 12.65 Bn
Jun 30, 2025 12.77 Bn
Mar 31, 2025 12.61 Bn
Dec 31, 2024 12.63 Bn
Sep 30, 2024 12.26 Bn
Jun 30, 2024 12.01 Bn
Mar 31, 2024 11.84 Bn
Dec 31, 2023 12.13 Bn
Sep 30, 2023 11.60 Bn
Jun 30, 2023 11.53 Bn
Mar 31, 2023 11.50 Bn
Dec 31, 2022 11.85 Bn
Sep 30, 2022 11.50 Bn
Jun 30, 2022 11.75 Bn
Mar 31, 2022 11.85 Bn
Dec 31, 2021 12.19 Bn
Sep 30, 2021 12.95 Bn